LymeHP (Energique, Inc.)
Welcome to the PulseAid listing for the Lyme drug offered from Energique, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Energique, Inc. |
| NON-PROPRIETARY NAME: | Baptisia Tinctoria, Echinacea (Angustifolia), Hydrastis Canadensis, Borrelia Burgdorferi Nosode, Babesia Microti, Ehrlichia Nosode (Canine), Encephalitis Nosode, Meningococcus Nosode, Hepatitis B Noso |
| SUBSTANCE NAME: | BAPTISIA TINCTORIA ROOT; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; BORRELIA BURGDORFERI; BABESIA MICROTI; EHRLICHIA CANIS; JAPANESE ENCEPHALITIS VIRUS; NEISSERIA MENINGITIDIS; HEPATITIS B VIRUS; ARSENIC TRI |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | LIQUID |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2017-09-06 |
| END MARKETING DATE: | 0000-00-00 |
Lyme HP HUMAN PRESCRIPTION DRUG Details:
| Item Description | Lyme HP from Energique, Inc. |
| LABELER NAME: | Energique, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3; 3; 6; 12; 20; 20; 30; 30; 38; 30; 30; 30; 30; 30; 30; 30; 30; 30([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL) |
| START MARKETING DATE: | 2017-09-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 44911-0438_f0a0f37b-0a5e-4ca1-bc0d-9d89b296083e |
| PRODUCT NDC: | 44911-0438 |
| APPLICATION NUMBER: | |
Other BAPTISIA TINCTORIA ROOT; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; BORRELIA BURGDORFERI; BABESIA MICROTI; EHRLICHIA CANIS; JAPANESE ENCEPHALITIS VIRUS; NEISSERIA MENINGITIDIS; HEPATITIS B VIRUS; ARSENIC TRI Pharmaceutical Manufacturers / Labelers:
